Electronic structure of BeH2

Nonorthogonal single‐configuration and multiconfiguration ab initio calculations are carried out on the BeH₂ molecule in its equilibrium (D_∞h) geometry, using a highly optimized even‐tempered Slater‐type orbital (STO) basis set. The results are used as a basis for a discussion of the electronic structure of the molecule in modern‐VB terms. A value of R_e = 1.329 Å is obtained. Values are also obtained for the symmetric‐stretch harmonic frequency (2053 cm^?1), electric quadrupole moment (?5.60 Buckingham), and nuclear quadrupole coupling constants (?3.59 MHz for ⁹Be and 0.0915 MHz for ²H). © 2005 Wiley Periodicals, Inc. Int J Quantum Chem, 2006     

取代基效应与乙烯-α-烯烃共聚物的序列结构——5.乙烯-乙烯醇共聚物

本文应用取代基效应(SCS)方法研究了乙烯-乙烯醇(EVA)共聚物,得到了羟基(-OH)在两种不同溶剂中的SCS参数:在苯酚+重水(80/20W/W)中参数为S_1=42.77±0.08ppm,S_2=7.155±0.06ppm,S_3(s)=-4.08±0.02ppm,S_3(t)=-3.09±0.02ppm,S_4=0.48±0.03ppm,S_5=0.26±0.05ppm,在以邻二氯苯为溶剂时参数为S_1=44.97±0.61ppm,S_2=7.40±0.00ppm,S_3(s)=-4.51±0.17ppm,S_3(t)=-3.13±0.00ppm,S_4=0.63±0.04ppm,S_5=0.36±0.00ppm,同时利用所得到的SCS参数对该共聚物的~(13)C NMR谱进行了归属。     

Self-consistent-field – Hartree–Fock method with finite nuclear mass corrections

We have upgraded a Self-consistent-field – Hartree–Fock routine to include a finite nuclear mass correction for molecules developed in our laboratory. The new routine can handle isotopomers without calculating any nuclear kinetic energy matrix element. Tests on H₂, LiH, HF, F₂, and H₂O isotopomers indicate the equivalence of our correction to the standard diagonal adiabatic correction. A further original application to C₂H₆ illustrates the usefulness of the method for polyatomic molecules. The resulting molecular orbitals carry the nuclear mass signature, exemplified with Koopmans ionization potentials.From the Proceedings of the 28th Congreso de Químicos Teóricos de Expresión Latina (QUITEL 2002)     

Preparation and characterisation of thermoresponsive poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs

Despite the large number of publications and patents concerning pH/thermoresponsive polymers, few data are available concerning the preparation of thermoresponsive cross-linked microspheres from preformed polymers. Therefore, N-isopropylacrylamide-co-acrylamide-co-(2-hydroxyethyl acrylate) copolymers were obtained as a new thermoresponsive material with a lower critical solution temperature (LCST) around 36 degrees C, in phosphate buffer at pH 7.4, and with a cross-linkable OH group in their structure. The LCST value was determined both by UV spectroscopy and microcalorimetric analysis. These copolymers were solubilised in acidified aqueous solution below their LCST, dispersed in mineral oil, and transformed into stable microspheres by cross-linking with glutaraldehyde. The thermoresponsive microspheres were characterised by optical and scanning electron microscopy, degree of swelling, and water retention. The pore dimensions of the microspheres and the retention volumes of some drugs and typical compounds were evaluated at different temperatures by liquid chromatography. Indomethacin, as a model drug, was included in the microspheres by the solvent evaporation method. Finally, the influence of temperature and of temperature cycling on drug release was investigated.     

A preliminary study on fabrication of nanoscale fibrous chitosan membranes in situ by biospecific degradation

A new approach for in situ fabrication of nanoscale fibrous chitosan membrane by biospecific degradation under physiological situation was studied. The chitosan binary blend membranes were fabricated by solvent casting of chitosan solution containing highly deacetylated chitosan (HDC) and moderately deacetylated chitosan (MDC) with different ratio. The biodegradation process was performed in PBS (pH 7.4) containing lysozyme at the temperature of 37 °C. Experimental results from weight loss, reducing sugar in surrounding media, FT-IR, X-ray diffraction, gel permeation chromatography (GPC) and SEM throughout the study showed that the biospecific degradation by lysozyme had removed MDC component selectively. When the ratio of MDC in the binary blend membranes amounted to 0.5, nanoscale domains of HDC and MDC were obtained, and thus a nanoscale fibrous structure was fabricated after biospecific degradation of MDC. This nanofibrous structure and the biospecific degradation of chitosan membranes can have potential advantages and interesting implications in tissue engineering and drug delivery.     

Synthesis and Evaluation of Biocompatible pH‐Sensitive Hydrogels as Colon‐Specific Drug Delivery Systems

Because of the growing importance of pH‐sensitive hydrogels as drug delivery systems, biocompatible copolymeric hydrogels based N‐vinyl‐2‐pyrrolidinone (NVP) and methacrylic acid (MAA) were designed and synthesized. These hydrogels were investigated for oral drug delivery. Radical copolymerizations of N‐vinyl‐2‐pyrrolidinone (NVP) and methacrylic acid (MAA) with the various ratios of cross‐linking agent were carried out at 70 °C. Azabisisobutyronitrile (AIBN) was the free‐radical initiator employed and Cubane‐1,4‐dicarboxylic acid (CDA) linked to two 2‐hydroxyethyl methacrylate (HEMA) group was the crosslinking agent (CA) used for hydrogel preparations. The hydrogels were characterized by differential scanning calorimetry and FT‐IR. Equilibrium swelling studies were carried out in enzyme‐free simulated gastric and intestinal fluids (SGF and SIF, respectively). A model drug, olsalazine [3,3′‐azobis (6‐hydroxy benzoic acid)] (OSZ) as an azo derivative of 5‐aminosalicylic acid (5‐ASA), was entrapped in these gels and the in‐vitro release profiles were established separately in both enzyme‐free SGF and SIF. The drug‐release profiles indicated that the amount of drug released depended on the degree of swelling. The swelling was modulated by the amount of crosslinking of the polymer bonded drug (PBDs) prepared. Based on the great difference in hydrolysis rates at pH 1 and 7.4, these pH‐sensitive hydrogels appear to be good candidates for colon‐specific drug delivery.     

Dexamethasone delivery to posterior segment of the eye

Due to anatomic barriers and lacrimal drainage it is difficult to obtain therapeutic drug concentrations in the posterior part of the eye after topical drug administrations. Lipophilic cyclodextrins, such as randomly methylated β-cyclodextrin (RMβCD), are known to act both as solubilizers of water-insoluble drugs in aqueous solutions and as penetration enhancers that reduce the barrier function of lipophilic membranes. The purpose of this study was to investigate the effects of RMβCD on dexamethasone delivery from aqueous eye drop solution into rabbit eyes. Dexamethasone (0.5 and 1.5% w/v) drops (50 μl) were administered to the left eye of rabbits (n = 6) and the drug levels measured in different eye tissues 2 h after administration. In aqueous humor dexamethasone levels were 1,190 ± 110 and 1,670 ± 630 ng/g (mean ± SD) after administration of the 0.5 and 1.5% dexamethasone eye drops, respectively. In the retina the levels were 33 ± 7 and 66 ± 49 ng/g, and in optic nerve 41 ± 12 and 130 ± 50 ng/g, respectively. In a previous study the dexamethasone concentration in aqueous humor after topical administration of 1.3% (w/v) dexamethasone eye drops in aqueous 2-hydroxypropyl-β-cyclodextrin (HPβCD) solution was determined to be 320 ± 230 ng/g and 66 ± 20 ng/g after administration of Maxidex^® eye drops. Both the hydrophilic HPβCD and the lipophilic RMβCD enhance topical dexamethasone delivery into the eye, but of the two, the lipophilic RMβCD results in higher dexamethasone concentrations.     

6-甲氧基-2-丙酰基萘在醇溶剂中的溴化反应

室温下，6－甲氧基－2－丙酰基萘和1，3－二溴－5，5－二甲基海因的溴化反应在醇溶剂中，反应速度快、转化率高，生成5－溴－6－甲氧基－2－丙酰基萘的收率高（98．59％）。     

Magnetic microcapsules for targeted delivery of anticancer drugs

To achieve targeted distribution of anticancer drugs with sustained activity, ferromagnetic ethylcellulose microcapsules containing an anticancer drug, mitomycin C (FM-MMC-mc), were prepared by a method based on phase separation principles. Two prototypes of FM-MMC-mc were made: one with the drug as the core and zinc ferrite on its capsular surface (outer type); the other with both the drug and zinc ferrite as the core (inner type). Both preparations provided a sustained-release property and a sensitive response to conventional magnetic force, although certain differences in the release rate of drug, magnetic responsiveness, and particle size were found between the two dosage forms. Animal studies showed that the magnetic microcapsules could be magnetically controlled in the artery and urinary bladder. VX2 tumors in the rabbit hind limb and urinary bladder were successfully treated with magnetic control of FM-MMC-mc. Pharmacokinetic study revealed that the targeting of the microcapsules markedly enhanced the drug absorption into the surrounding tissues for a prolonged period of time. The results indicate the feasibility and effectiveness of the magnetic microcapsules as a targeted drug delivery system.     

碳碳相关谱测定泽泻萜醇F的结构

从泽泻中分离出新化合物泽泻萜醇F，采用二维核磁共振碳相关技术研究了该化合物的骨架结构。结合碳碳相关谱及远程碳氢相关谱等其它二维核磁共振技术，分析了该化合物的常规氢谱和碳谱，并准确归属了质子和碳核的化学位移。